194 related articles for article (PubMed ID: 37702983)
1. Chemotherapy-Induced Peripheral Neuropathy: Diagnosis, Agents, General Clinical Presentation, and Treatments.
Molinares D; Kurtevski S; Zhu Y
Curr Oncol Rep; 2023 Nov; 25(11):1227-1235. PubMed ID: 37702983
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort.
Sreeram K; Seaton R; Greenwald MK; Kamgar M; Assad H; Baird T; Schwartz AG; Ruterbusch J; Simon MS
Cancer Causes Control; 2023 May; 34(5):459-468. PubMed ID: 36934365
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
4. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
Bonhof CS; Trompetter HR; Vreugdenhil G; van de Poll-Franse LV; Mols F
Support Care Cancer; 2020 Dec; 28(12):5933-5941. PubMed ID: 32281032
[TBL] [Abstract][Full Text] [Related]
5. Newly identified chemotherapy-induced peripheral neuropathy in a childhood cancer survivorship clinic.
Rodwin RL; Ross WL; Rotatori J; Allen K; Auerbach C; Balsamo LM; Kadan-Lottick NS
Pediatr Blood Cancer; 2022 Mar; 69(3):e29550. PubMed ID: 34971076
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy-induced peripheral neuropathy: characteristics, diagnosis and treatment].
Istenes I; Nagy Z; Demeter J
Magy Onkol; 2016 Jun; 60(2):165-75. PubMed ID: 27275643
[TBL] [Abstract][Full Text] [Related]
7. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the online Acceptance and Commitment Therapy intervention "Embrace Pain" for cancer survivors with chronic painful chemotherapy-induced peripheral neuropathy: study protocol for a randomized controlled trial.
van de Graaf DL; Mols F; Trompetter HR; van der Lee ML; Schreurs KMG; Børøsund E; Nes LS; Smeets T
Trials; 2022 Aug; 23(1):642. PubMed ID: 35945582
[TBL] [Abstract][Full Text] [Related]
9. Health-Related Quality of Life in Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Clinical Trial.
Bao T; Baser R; Chen C; Weitzman M; Zhang YL; Seluzicki C; Li QS; Piulson L; Zhi WI
Oncologist; 2021 Nov; 26(11):e2070-e2078. PubMed ID: 34390283
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy-induced peripheral neuropathy; impact on quality of life].
Scheel A; Beijers AJ; Mols F; Faber CG; Vreugdenhil G
Ned Tijdschr Geneeskd; 2014; 158():A7455. PubMed ID: 25315326
[TBL] [Abstract][Full Text] [Related]
11. Lived experiences and support needs of women who developed chemotherapy-induced peripheral neuropathy following treatment for breast and ovarian cancer.
Tanay MA; Armes J
Eur J Cancer Care (Engl); 2019 May; 28(3):e13011. PubMed ID: 30790382
[TBL] [Abstract][Full Text] [Related]
12. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy.
McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB
Support Care Cancer; 2019 Oct; 27(10):3849-3857. PubMed ID: 30756229
[TBL] [Abstract][Full Text] [Related]
13. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
[TBL] [Abstract][Full Text] [Related]
14. Is CT-based body composition associated with long-term chemotherapy-induced peripheral neuropathy in colorectal cancer survivors?
Smit D; Mols F; Bonhof CS; Bours MJL; Vreugdenhil G; Beijer S
Support Care Cancer; 2022 Jul; 30(7):6071-6078. PubMed ID: 35416503
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Patient-Reported Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Survivors.
Teng C; ; Blinman PL; Vardy JL
J Natl Compr Canc Netw; 2022 Dec; 20(12):1308-1315. PubMed ID: 36509075
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced peripheral neuropathy: Current status and progress.
Brewer JR; Morrison G; Dolan ME; Fleming GF
Gynecol Oncol; 2016 Jan; 140(1):176-83. PubMed ID: 26556766
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in understanding chemotherapy-induced peripheral neuropathy.
Gordon-Williams R; Farquhar-Smith P
F1000Res; 2020; 9():. PubMed ID: 32201575
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-Induced Peripheral Neuropathy.
Chen CS; Hertz DL
Handb Exp Pharmacol; 2023; 277():299-337. PubMed ID: 36253554
[TBL] [Abstract][Full Text] [Related]
19. The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy.
Tofthagen CS; Cheville AL; Loprinzi CL
Curr Oncol Rep; 2020 Apr; 22(5):50. PubMed ID: 32323068
[TBL] [Abstract][Full Text] [Related]
20. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.
Loprinzi CL; Lacchetti C; Bleeker J; Cavaletti G; Chauhan C; Hertz DL; Kelley MR; Lavino A; Lustberg MB; Paice JA; Schneider BP; Lavoie Smith EM; Smith ML; Smith TJ; Wagner-Johnston N; Hershman DL
J Clin Oncol; 2020 Oct; 38(28):3325-3348. PubMed ID: 32663120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
